SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-11-057715
Filing Date
2011-11-28
Accepted
2011-11-28 16:43:20
Documents
1
Period of Report
2011-11-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd326532.html 4  
1 FORM 4 rrd326532.xml 4 10128
  Complete submission text file 0001181431-11-057715.txt   11527
Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Issuer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O OXIGENE, INC., 230 THIRD AVENUE WALTHAM MA 02451
Business Address
Schwieterman William D (Reporting) CIK: 0001403961 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51462 | Film No.: 111228810